Group One Trading’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Group One Trading’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,900	Closed	-$1.42K	–	8568
2024 Q4	$1.42K	Buy	1,900 +1,400	+280%	+$1.4K	﹤0.01%	6824
2024 Q3	$610	Buy	500 +200	+67%	+$318	﹤0.01%	6370
2024 Q2	$621	Sell	300 -100	-25%	-$236	﹤0.01%	6430
2024 Q1	$1.46K	Buy	+400	New	+$1.53K	﹤0.01%	6555
2023 Q3	–	Sell	-1,300	Closed	-$7.28K	–	8447
2023 Q2	$7.28K	Buy	+1,300	New	+$10.2K	﹤0.01%	6551

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Group One Trading's OMGA Position: Q1 2025 in Review

Group One Trading sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 900 shares — an estimated $671 sold.

Group One Trading first reported a position in OMGA in Q1 2023 and held it in 7 quarters. The position peaked at $18.5K in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Group One Trading reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Group One Trading sold 900 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $671.
Group One Trading first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Group One Trading's Omega Therapeutics, Inc. Common Stock position peaked at $18.5K in Q1 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.